Косметика өндірісі мен технологиясына кіріспе
жүктеу/скачать 16,24 Mb. Pdf көрінісі
|
b436ce0a649361871333ff7a454fb4e8 original.17032999
| Contact Dermatitis
. 1997;36:240 – 243. 57. Cox, D. R.: Fundamental emulsion science, Part 1. H PC Today . 2012;7(3):28-31. 58. Leal-Calderon, F.: Emulsified lipids: formulation and control of end-use properties. OCL . 2012;19(2):111 – 119. 59. Weiss, J., Canceliere, C., McClements, D. J.: Mass transport phenomena in oil-in-water emulsions containing surfactant micelles: Ostwald ripening.
. 2000;16:6833 – 6838. 60. De Paula, I. C.: Development of ointment formulations prepared with Achyrocline sat- ureioides spray-dried extracts.
. 1998.24(3):235 – 241. 61. Stable Micro Systems, Accessed 1/14/2014 at http://www.stablemicrosystems.com/ frameset.htm?http://www. stablemicrosystems.com/TextureAnalysisAttachments.htm 62. ASTM D1173 - 07 Standard Test Method for Foaming Properties of Surface-Active Agents, Accessed 1/2/2014 at http://www.astm.org/Standards/D1173.htm 63.
Rosen, M. J., Solash, J.: Factors affecting initial foam height in the Ross-Miles foam test. J Am Oil Chem Soc . 1969;46(8):399 – 402. 64. Weaire, D. L., Hutzler, S.: The Physics of Foams , Oxford: Oxford University Press, 2001: 51. 65. Borole, S. N., Caneba, G. T.: Foaming characteristics of vinyl acetate-acrylic acid (VA-AA) copolymer-based surfactants. J Funct Mater Res . 2013;1(1):6 – 16. 66. KRÜSS: Dynamic Foam Analyzer, Accessed 11/9/2013 at http://www.kruss.de/ products/foam-analysis/dfa100/ dynamic-foam-analyzer-dfa100/ 67. FDA: BAM – Microbiological Methods for Cosmetics, Last update: 4/8/2013, Accessed 4/13/2014 at http:// www.fda.gov/Food/FoodScienceResearch/ LaboratoryMethods/ucm073598.htm 68. Yablonski, J. I., Mancuso, S. E.: Preservative efficacy testing: accelerating the process. Cosmet Toiletries . 2007;122(10):51 – 62. 69. USP Antimicrobial effectiveness testing, Section 51, 28th Edition, Rockville: United States Pharmacopeial Convention, 2005. 70.
Siegert, W.: Evaluation of the microbiological safety of finished cosmetic products, Euro- Cosmetics . 2010;3. 71. WHO Guidelines on Hand Hygiene in Health Care: First Global Patient Safety Challenge Clean Care Is Safer Care, Accessed 12/13/2013 at http://www.ncbi.nlm.nih.gov/books/NBK144013/pdf/TOC.pdf 72.
Woolwine, F. S., Gerberding, J. L.: Effect of testing method on apparent activities of antivi- ral disinfectants and antiseptics. Antimicrob Agents Chemother . 1995;39:921 – 923. 73. FDA Tentative final monograph for healthcare antiseptic drug products; proposed rule. Fed Reg . 1994:31441 – 31452. 74.
CDC: Boyce, J. M., Pittet, D.: Guideline for Hand Hygiene in HealthCare Settings, 2002;51(RR16);1 – 44, Accessed 12/2/2013 at http://www.cdc.gov/ mmwr/preview/mmwrhtml/rr5116a1.htm 75.
Elder, R. L.: Final report on the safety assessment of methylparaben, ethylparaben, propy- lparaben, and butlyparaben. J Am Coll Toxicol . 3:149 – 209. 76. Darbre, P. D., Aljarrah, A., Miller, W. R., et al.: Concentrations of parabens in human breast tumours. J Appl Toxicol . 2004;24(1):5-13. 77. American Cancer Society: Antiperspirants and Breast Cancer Risk, Last update: 9/20/2013, Accessed 8/12/14 at http://www.cancer.org/cancer/cancer causes/othercarcinogens/athome/antiperspirants-and-breast- cancer-risk 78.
Mirick, D. K., Davis, S., Thomas, D. B.: Antiperspirant use and the risk of breast cancer.
. 2002;16;94(20):1578 – 1580. 79. Routledge, E. J., Parker, J., Odum, J., et al.: Some alkyl hydroxy benzoate preservatives
(parabens) are estrogenic. Toxicol Appl Pharmacol . 1998;153(1):12 – 19. 80. SCCS: Opinion on Parabens SCCS/1348/10, 12/14/2010, Last revision: 3/22/2011, 81. Accessed 8/12/14 at http://ec.europa.eu/health/scientific_committees/consumer_safety/ docs/sccs_o_041.pdf 82. SCCS: Clarification on Opinion SCCS/1348/10 in the Light of the Danish Clause of Safeguard Banning the Use of Parabens in Cosmetic Products Intended for Chil- dren under Three Years of Age (SCCS/1446/11), 10/10/2011, Accessed 8/12/14 at http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/ 175 sccs_o_069.pdf 83. CIR Expert Panel Meeting: Parabens, 2012. Accessed 8/12/14 at http://www.cir-safety.org/sites/default/files/ paraben_build.pdf 84.
Allisonn E., Aiello, A. E., Larson, E. L., et al.: Consumer antibacterial soaps: effective or just risky? Clin Infect Dis . 2007;45(2):S137 – S147. 85. Larson, E., Aiello, A., Lee, L. V., et al.: Short- and long-term effects of handwashing with antimicrobial or plain soap in the community. J Community Health . 2003;28:139 – 50. 86. Dann, A. B., Hontela, A.: Triclosan: environmental exposure, toxicity and mechanisms of action. J Appl Toxicol . 2011;31(4):285 – 311. 87. Beradesca, E., Fideli, D., Gabba, P., et al.: Ranking of surfactant skin irritancy in vivo in man using the plastic occlusion stress test (POST).
. 1990;23;1 – 5. 88. Lee, C. H., Maibach, H. I.: The sodium lauryl sulfate model: an overview. Contact Der- matitis . 1995;33(1):1 – 7. 89.
Final report on the safety assessment of sodium lauryl sulfate and ammonium lauryl sul- fate. Int J Toxicol. 1983;2:127 – 181. 90. De Jongh, C. M., Verberk, M. M., Withagen, C. E., et al.: Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis . 2006;54(6):325 – 333. 91. Soap and Detergent Association: Sodium Lauryl Sulfate, Accessed 12/2/2013 at http://www.cleaningproductfacts. com/sodium-lauryl-sulfate.htm 92.
CIR: SLS, Accessed 12/2/2013 at http://www.cir-safety.org/sites/default/files/imports/ alerts.pdf 93. Browne, M. A., Galloway, T., Thompson, R.: Microplastic – an emerging contaminant of potential concern? Integr Environ Assess Manage . 2007;3:559 – 561. 94. Fendall, L. S., Sewell, M. A.: Contributing to marine pollution by washing your face: Microplastics in facial cleansers. Mar Pollut Bull . 2009;58(8):1225 – 1228. |